Bayer Cash on Hand 2010-2025 | BAYRY | MacroTrends

Bayer Cash on Hand 2010-2025 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for the quarter ending March 31, 2025 was $5.672B, a 41.44% decline year-over-year.

Bayer cash on hand for 2024 was $9.151B, a 21.29% decline from 2023.
Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.
Bayer cash on hand for 2022 was $10.935B, a 16.91% increase from 2021.

Bayer Cash on Hand 2010-2025 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for 2024 was $9.151B, a 21.29% decline from 2023.
Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.
Bayer cash on hand for 2022 was $10.935B, a 16.91% increase from 2021.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$796.4B
Johnson & Johnson (JNJ)	$379.5B
AbbVie (ABBV)	$306B
Novo Nordisk (NVO)	$260.6B
Roche Holding AG (RHHBY)	$248.1B
Novartis AG (NVS)	$234.2B
Merck (MRK)	$196.7B
Sanofi (SNY)	$128.6B
Pfizer (PFE)	$125.6B
Innoviva (INVA)	$1.1B